Market Tracker

01/17 3:52am ET

ResMed Inc (NYSE:RMD)

65.33
Delayed Data
As of Jan 13
 +1.07 / +1.67%
Today’s Change
52.37
Today|||52-Week Range
70.90
+5.29%
Year-to-Date
ResMed (RMD) Q2 Earnings: Disappointment in the Cards?
Jan 13 / Zacks.com - Paid Partner Content
ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders
Jan 09 / Zacks.com - Paid Partner Content
Why a Massive Short Squeeze Could Send These 4 Stocks Into Orbit
Jan 11 / TheStreet.com - Paid Partner Content
ResMed Achieves Key Milestone in Sleep-Disordered Breathing
Jan 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close64.26
Today’s open64.68
Day’s range64.52 - 65.78
Volume696,496
Average volume (3 months)883,813
Market cap$9.2B
Dividend yield2.02%
Data as of 4:02pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+0.81%
Earnings growth (this year)+3.81%
Earnings growth (next 5 years)+10.61%
Revenue growth (last year)+9.52%
P/E ratio26.7
Price/Sales4.87
Price/Book5.42

Competitors

 Today’s
change
Today’s
% change
VARVarian Medical Syste...+0.53+0.59%
NVRONevro Corp+2.12+2.47%
LIVNLivaNova PLC+0.05+0.11%
SPNCSpectranetics Corp+0.75+3.03%
Data as of 01/13/2017

Financials

Next reporting dateJanuary 24, 2017
EPS forecast (this quarter)$0.69
Annual revenue (last year)$1.8B
Annual profit (last year)$352.4M
Net profit margin19.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Mick Farrell
President &
Chief Operating Officer
Rob Douglas
Corporate headquarters
San Diego, California

Forecasts